Radio and PodcastLive Radio & PodcastsScience & Medicine
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!
Oncology Times Broadcast News Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue! Cornelis van de Velde at ECCO15-ESMO34 on the largest comparis...
About This Episode
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! is an episode from Oncology Times Broadcast News. Oncology Times Broadcast News Aromatase Inhibitor...
Podcast
This episode belongs to Oncology Times Broadcast News.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 6, 2009, 00:06:57 long, audio available.
Related Episodes
Continue listening to more episodes from Oncology Times Broadcast News.
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
Sep 28, 2009 - 00:07:19
For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
Sep 28, 2009 - 00:06:03
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer
Sep 28, 2009 - 00:09:05
"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer
Sep 28, 2009 - 00:02:18